LEADER 04667nam 2200625 a 450 001 9910457825703321 005 20200520144314.0 010 $a1-283-31755-9 010 $a9786613317551 010 $a1-61705-019-9 035 $a(CKB)2550000000063677 035 $a(EBL)787865 035 $a(OCoLC)758334168 035 $a(SSID)ssj0000539475 035 $a(PQKBManifestationID)12232431 035 $a(PQKBTitleCode)TC0000539475 035 $a(PQKBWorkID)10585211 035 $a(PQKB)11297638 035 $a(MiAaPQ)EBC787865 035 $a(Au-PeEL)EBL787865 035 $a(CaPaEBR)ebr10509680 035 $a(CaONFJC)MIL331755 035 $a(EXLCZ)992550000000063677 100 $a20110608d2012 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aNeurologic complications of cancer therapy$b[electronic resource] /$f[edited by] Patrick Y. Wen, David Schiff, Eudocia C. Quant 210 $aNew York $cdemos Medical$dc2012 215 $a1 online resource (439 p.) 300 $aDescription based upon print version of record. 311 $a1-936287-07-2 320 $aIncludes bibliographical references and index. 327 $aNeurologic complications of alkylating agent chemotherapy / Herbert B. Newton -- Neurologic complications of antimetabolites / Ryan Merrell, Jorg Dietrich, and Tracy Batchelor -- Neurologic complications associated with plant alkaloids / Abhishek Singla, Aditya Bardia, and Vinay Chaudhry -- Neurologic complications of topoisomerase inhibitors / April F. Eichler -- Neurologic complications of epothilones and amino acid degraders / April F. Eichler -- Neurologic complications of corticosteroids / Erin M Dunbar, Rizwan Kalani, and Santosh Kesari -- Neurologic complications of immunomodulatory agents / Stuart C. Apfel -- Neurologic complications of immunosuppressive drugs / Ramani Balu and Amy A.Pruitt -- Neurologic complications associated with biologic agents / Aaron G. Mammoser and Morris D. Groves -- Neurologic complications of targeted therapy / Eudocia C. Quant ... [et al.] -- Neurologic complications of hormonal chemotherapies / Wendy Sherman Sojka and Jeffrey Raizer -- Neurologic complications associated with supportive therapies / Jan Drappatz -- Chemotherapy-associated cognitive dysfunction / Jorg Dietrich and Alexander Pine -- Central nervous system toxicity of chemotherapy / Jerome J. Graber and Lisa M. DeAngelis -- Neurologic complications affecting peripheral nerves / Guido Cavaletti and Paola Marmiroli -- Neurologic complications affecting muscles and the neuromuscular junction / Kelly G. Gwathmey, Ted M. Burns, and Elliot L. Dimberg -- Cellular mechanisms of radiation injury to cognition / Michelle Monje -- Central nervous system complications of radiation therapy / Damien Ricard ... [et al.] -- Radiation-induced tumors / Hilary L. Somerset, B.K. Kleinschmidt-DeMasters, and Kevin O. Lillehei -- Radiation vasculopathy / Lisa R. Rogers -- Radiation myelopathy / Timothy E. Schultheiss -- Radiation-induced peripheral nerve disorders / Odysseas Kargiotis and Athanasios P. Kyritsis -- Complications of neurosurgical oncology / Brian J. Williams, Robert G. Louis, and Mark E. Shaffrey -- Neurologic complications of hematopoietic stem cell transplantation / Eudocia C. Quant and Patrick Y. Wen. 330 $aNeurologic side effects of cancer therapy can inhibit treatment, can be dose-limiting and can diminish quality-of-life. Neurotoxicity related to cancer therapy is a common problem in oncology practice and in clinical neurology. Recognition of neurologic complications of anticancer therapy is necessary due to potential confusion with metastatic disease, paraneoplastic syndromes or comorbid neurologic disorders that do not require reduction or discontinuation of therapy. Neurologic Complications of Cancer Therapy provides comprehensive coverage of the recognition and management of neurologic sym 606 $aCancer$xTreatment$xComplications 606 $aCancer$xTreatment 606 $aNeurologic manifestations of general diseases 608 $aElectronic books. 615 0$aCancer$xTreatment$xComplications. 615 0$aCancer$xTreatment. 615 0$aNeurologic manifestations of general diseases. 676 $a616.99/406 701 $aWen$b Patrick Y$01051379 701 $aSchiff$b David$f1959-$0967491 701 $aLee$b Eudocia Quant$01051380 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910457825703321 996 $aNeurologic complications of cancer therapy$92481852 997 $aUNINA LEADER 02022oam 2200565M 450 001 9910716119703321 005 20200213070935.9 035 $a(CKB)5470000002518921 035 $a(OCoLC)1065616476 035 $a(OCoLC)995470000002518921 035 $a(EXLCZ)995470000002518921 100 $a20071213d1926 ua 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aSurface water supply of Hawaii, July 1, 1922, to June 30, 1923. Nathan C. Grover, chief hydraulic engineer. E.D. Burchard, district engineer. [U.S. Geological Survey Bulletin Water Supply Paper 575.] 210 1$a[Washington, D.C.] :$c[U.S. Government Printing Office],$d1926. 215 $a1 online resource (177 pages) $ctables 225 1 $aHouse document / 69th Congress, 1st session. House ;$vno. 69 225 1 $a[United States congressional serial set ] ;$v[serial no. 8623] 300 $aTable of contents, p. III. 300 $aIndex, p. 171. 300 $aBatch processed record: Metadata reviewed, not verified. Some fields updated by batch processes. 300 $aFDLP item number not assigned. 606 $aBodies of water 606 $aRivers 606 $aStream measurements 606 $aStreamflow 606 $aWater 606 $aWater-supply 608 $aLegislative materials.$2lcgft 615 0$aBodies of water. 615 0$aRivers. 615 0$aStream measurements. 615 0$aStreamflow. 615 0$aWater. 615 0$aWater-supply. 701 $aBurchard$b E. D$01398124 701 $aGrover$b Nathan Clifford$0831603 712 02$aGeological Survey (U.S.) 801 0$bWYU 801 1$bWYU 801 2$bOCLCO 801 2$bOCLCQ 906 $aBOOK 912 $a9910716119703321 996 $aSurface water supply of Hawaii, July 1, 1922, to June 30, 1923. Nathan C. Grover, chief hydraulic engineer. E.D. Burchard, district engineer.$93515023 997 $aUNINA